Home › Medulloblastoma › New York
Medulloblastoma clinical trials in New York
5 studies for Medulloblastoma are looking for participants at sites in New York.
Cities in New York
Digoxin Medulloblastoma Study
- Montefiore Medical Center, The Bronx
RecruitingPhase 2
12 Months – 30 Years · All sexes · Updated Aug 26, 2026 · NCT06701812A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
- Albany Medical Center, Albany
- Roswell Park Cancer Institute, Buffalo
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- and 5 more
RecruitingPhase 3
Ages 4 to 21 · All sexes · Updated Aug 25, 2026 · NCT05382338Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma
- New York University, New York
- Columbia University Medical Center, New York
Recruiting
12 Months – 39 Years · All sexes · Updated Aug 11, 2026 · NCT05057702A Study of 177Lu-DTPA-Omburtamab in Children and Adolescents With Brain Cancer or Cancer That Has Spread to the Central Nervous System (CNS)
- Memorial Sloan Kettering at Suffolk-Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering at Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- and 1 more
RecruitingPhase 1
Ages 3 to 22 · All sexes · Updated Jul 13, 2026 · NCT0769889968-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors.
- Weill Cornell Medicine, New York
RecruitingPhase 4
Ages 18 to 100 · All sexes · Updated Nov 21, 2025 · NCT04081701From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.